.png)
.png)
Chief Medical Officer
Biotia Inc.
Disclosure(s): Biotia Inc.: Employee of Biotia Inc. a for-profit biotechnology company, Stocks/Bonds
Dorottya Nagy-Szakal, MD, PhD, Chief Medical Officer, with 10+ years of experience in infectious diseases, AI-powered molecular diagnostics and translational medicine.
My career spans a range of areas from running successful clinical trials and building and overseeing clinical diagnostic laboratories to holding technical and practical workshops as well as invited talks at major international congresses. My industry expertise is deep rooted in academic and translational research with 25+ peer reviewed publications and over 30 international presentations spanning the fields of Microbiome, Pediatric Gastroenterology, Neuroscience, Clinical Microbiology, Infectious Diseases as well as Public Health.
At my current position as the Chief Medical Officer at Biotia and a Research Assistant Professor at SUNY Downstate, I am responsible to implement novel technologies at the laboratory, to achieve the highest quality of research by state standards, to provide clinical implementation of microbiome and virome data, and to engage healthcare leaders using our novel AI-driven technology in infectious disease diagnostics. During the current COVID-19 pandemic, I was able to achieve provisional New York State CLIA approval for the Biotia laboratory for SARS-CoV-2 testing and to validate and implement novel NGS diagnostics highlighting the importance of genomic epidemiology in viral pandemics.